Guangdong Biolight Meditech Co Ltd - Asset Resilience Ratio

Latest as of June 2026: 1.02%

Guangdong Biolight Meditech Co Ltd (300246) has an Asset Resilience Ratio of 1.02% as of June 2026. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. See how liquid is Guangdong Biolight Meditech Co Ltd's working capital to evaluate short-term liquidity relative to the company's equity base.

Liquid Assets

CN¥25.14 Million

≈ $3.68 Million USD Cash + Short-term Investments

Total Assets

CN¥2.45 Billion

≈ $359.07 Million USD All company assets

Resilience Assessment

Low

Financial Resilience Level

Asset Resilience Ratio Trend (2015–2024)

This chart shows how Guangdong Biolight Meditech Co Ltd's Asset Resilience Ratio has changed over time. For the complete balance sheet picture, see Guangdong Biolight Meditech Co Ltd asset portfolio.

Liquid Assets Composition Over Time

This chart breaks down Guangdong Biolight Meditech Co Ltd's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. Explore how much of Guangdong Biolight Meditech Co Ltd's assets are long-term investments to see how much of total assets are deployed in long-term investments.

Current Liquid Assets Breakdown

Component	Amount	% of Total Assets
Cash & Equivalents	CN¥0.00	0%
Short-term Investments	CN¥25.14 Million	1.02%
Total Liquid Assets	CN¥25.14 Million	1.02%

Asset Resilience Insights

Limited Liquidity: Guangdong Biolight Meditech Co Ltd maintains only 1.02% of assets in liquid form.
This low level may indicate efficient asset utilization but could pose risks during economic downturns.
The company has significant short-term investments, indicating active treasury management.

Guangdong Biolight Meditech Co Ltd Industry Peers by Asset Resilience Ratio

Compare Guangdong Biolight Meditech Co Ltd's asset resilience ratio with other companies in the same industry.

Company	Industry	Asset Resilience Ratio
Cochlear Ltd AU:COH	Medical Devices	9.76%
Jiangsu Yuyue Medical Equipment & Supply Co Ltd SHE:002223	Medical Devices	0.84%
Jafron Biomedical Co Ltd SHE:300529	Medical Devices	34.37%
Stratec SE XETRA:SBS	Medical Devices	0.29%
Shinhung KO:004080	Medical Devices	4.17%
DRTECH Corporation KQ:214680	Medical Devices	5.18%
Novacyt PA:ALNOV	Medical Devices	0.02%
Diagnostic Medical Systems SA PA:ALDMS	Medical Devices	1.48%

Annual Asset Resilience Ratio for Guangdong Biolight Meditech Co Ltd (2015–2024)

The table below shows the annual Asset Resilience Ratio data for Guangdong Biolight Meditech Co Ltd.

Year	Asset Resilience Ratio (%)	Liquid Assets	Total Assets	Change
2024-12-31	10.56%	CN¥263.97 Million ≈ $38.63 Million	CN¥2.50 Billion ≈ $365.66 Million	+7.32pp
2020-12-31	3.25%	CN¥52.20 Million ≈ $7.64 Million	CN¥1.61 Billion ≈ $235.18 Million	+0.13pp
2019-12-31	3.12%	CN¥30.00 Million ≈ $4.39 Million	CN¥961.46 Million ≈ $140.69 Million	+2.25pp
2016-12-31	0.87%	CN¥6.00 Million ≈ $877.99K	CN¥686.57 Million ≈ $100.47 Million	+0.19pp
2015-12-31	0.69%	CN¥4.00 Million ≈ $585.33K	CN¥580.65 Million ≈ $84.97 Million	--

pp = percentage points

About Guangdong Biolight Meditech Co Ltd

SHE:300246 China Medical Devices

Market Cap

$609.04 Million

CN¥4.16 Billion CNY

Market Cap Rank

#11337 Global

#3184 in China

Share Price

CN¥15.72

Change (1 day)

+4.73%

52-Week Range

CN¥7.83 - CN¥21.57

All Time High

CN¥30.12